Chronic Kidney Disease (CKD). Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Patients in the experimental group will participate in a 50-minute structured resistance training program that will be performed under the supervision of the researcher for the 1 initi
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Gender: male and female Age: middle-aged (40 to 65 years) Condition of dialysis: chronic hemodialysis -3 times a week - morning shift - Fresenius and Beibran machines (clinical file) Disease conditions: similar in terms of severity and degree, underlying diseases and medications (opinion of the attending physician and clinical file) BMI: 18 to 30, i.e. normal and overweight (measured by the researcher) Trainability and ability to perform resistance exercises (opinion and permission of the attending physician - initial assessment in the Pre-test) No special dietary or dietary restrictions (other than common restrictions in ESRD patients undergoing HD) (opinion of the attending physician and clinical file) Not doing specific exercise other than routine activities of life (interview with patient)
Exclusion criteria
Exclusion criteria: HB at study entry:less than 10 g/dl (clinical file) Resting systolic blood pressure greater than 140 mmHg within the past month (clinical file) Changes in dietary patterns and physical activity during the study compared to the beginning of the study (interview with patients)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-Blood biochemical parameters (urea, creatinine, phosphate, potassium, sodium, albumin, CRP, lactate and hemoglobin). Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: laboratory results.;Dialysis adequacy. Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: the standard Kt/V index.;Resting heart rate (RHR). Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: Pulse Oximeter.;Resting systolic and diastolic blood pressure (BP). Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: Standard and calibrated Mercury barometer.;Physical strength (hand grip strength and trunck strength). Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: Dynamometer.;Post Dialysis Fatigue level. Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: the standard FACIT questionnaire.;Quality of life (QOF). Timepoint: Beginning, middle (week 4) and end of the study (week 8). Method of measurement: the 36-item Short Form Health Questionnaire (SF-36) containing physical dimension scales (PCS) and mental dimension scales (MCS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShiva Mashinchi
Rasht University of Medical Sciences
Outcome results
None listed